# Adverse Drug Reactions to Cancer Therapies in Patients with Depression: Insights from VigiBase

> **NCT06801158** · — · COMPLETED · sponsor: **University Hospital, Caen** · enrollment: 8804863 (actual)

## Conditions studied

- Adverse Effects of Medical Drugs

## Interventions

- **DRUG:** use of anticancer drugs in monotherapy or in combination therapy

## Key facts

- **NCT ID:** NCT06801158
- **Lead sponsor:** University Hospital, Caen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-01
- **Primary completion:** 2025-01-15
- **Final completion:** 2025-01-16
- **Target enrollment:** 8804863 (ACTUAL)
- **Last updated:** 2025-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06801158

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06801158, "Adverse Drug Reactions to Cancer Therapies in Patients with Depression: Insights from VigiBase". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06801158. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*